Predni-Sediv
Brand names,
Predni-Sediv
Analogs
Predni-Sediv
Brand Names Mixture
Predni-Sediv
Chemical_Formula
C16H13Cl3N2OS
Predni-Sediv
RX_link
http://www.rxlist.com/cgi/generic3/tioconaz.htm
Predni-Sediv
fda sheet
Predni-Sediv
msds (material safety sheet)
Predni-Sediv
Synthesis Reference
No information avaliable
Predni-Sediv
Molecular Weight
387.711 g/mol
Predni-Sediv
Melting Point
No information avaliable
Predni-Sediv
H2O Solubility
No information avaliable
Predni-Sediv
State
Solid
Predni-Sediv
LogP
4.971
Predni-Sediv
Dosage Forms
Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)
Predni-Sediv
Indication
For the local treatment of vulvovaginal candidiasis (moniliasis).
Predni-Sediv
Pharmacology
Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.
Predni-Sediv
Absorption
Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.
Predni-Sediv
side effects and Toxicity
Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,
Predni-Sediv
Patient Information
Predni-Sediv
Organisms Affected
Yeast and other fungi